Komori
Sundrug (9989) · FactDecrease in cash and cash equivalents during the interim period

Increase in Cash and Cash Equivalents

First written in FY2021-Q2. 2 of 18 entries say "Restated". Latest entry: FY2027-H1.

18entries
7years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseOtherFY2021-Q2 – FY2027-H12020: 12021: 420212022: 420222023: 320232024: 220242025: 220252026: 22026
Same theme, other companies
Changes in Cash HoldingsA theme 151 companies write about · 99 as a headwind · 85 as a tailwind
Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Showing 14 of the 132 companies compared. The sentences above are computed from all 132.Comparing 199 of the theme's 218 threads.
Full recordFilings, disclosures and news, newest first
  1. FY2027-H1Decrease in cash and cash equivalents during the interim periodAnnual report

    「Cash and cash equivalents at the end of the interim consolidated accounting period, hereinafter referred to as "funds," decreased by ¥4,101 million from the end of the previous consolidated fiscal year to ¥66,421 million.」

    Cash and cash equivalents decreased by ¥4,101 million, from ¥70,523 million at the end of the previous fiscal year to ¥66,421 million.
  2. FY2026Full-year increase in cash and cash equivalentsAnnual report

    「Cash and cash equivalents at the end of the consolidated fiscal year increased by ¥5,567 million from the end of the previous consolidated fiscal year to ¥70,523 million.」

    Cash and cash equivalents increased from ¥64,956 million at the end of the previous fiscal year to ¥70,523 million.
  3. FY2026-H1Interim-period increase in cash and cash equivalentsAnnual report

    「Cash and cash equivalents at the end of the interim consolidated accounting period, hereinafter referred to as "funds," increased by ¥1,180 million from the end of the previous consolidated fiscal year to ¥66,137 million.」

    Cash and cash equivalents increased from ¥64,956 million at the end of the previous consolidated fiscal year to ¥66,137 million.
  4. FY2025Full-year decrease in cash and cash equivalentsAnnual report

    「Cash and cash equivalents at the end of the consolidated fiscal year, hereinafter referred to as "funds," decreased by ¥4,742 million from the end of the previous consolidated fiscal year to ¥64,956 million.」

    Cash and cash equivalents decreased by ¥4,742 million, from ¥69,698 million at the end of the previous fiscal year to ¥64,956 million.
  5. FY2025-H1Decrease in cash and cash equivalents during the interim periodAnnual report

    「Cash and cash equivalents at the end of the interim consolidated accounting period, hereinafter referred to as "funds," decreased by ¥6,304 million from the end of the previous consolidated fiscal year to ¥63,394 million.」

    Cash and cash equivalents decreased by ¥6,304 million, from ¥69,698 million at the end of the previous fiscal year to ¥63,394 million.
  6. FY2024Full-year decrease in cash and cash equivalentsAnnual report

    「Cash and cash equivalents at the end of the consolidated fiscal year, hereinafter referred to as "funds," decreased by ¥11,173 million from the end of the previous consolidated fiscal year to ¥69,698 million.」

    Cash and cash equivalents decreased by ¥11,173 million, from ¥80,872 million at the end of the previous fiscal year to ¥69,698 million.
  7. FY2024-Q2RestatedAnnual report

    「Cash and cash equivalents at the end of the cumulative second quarter, hereinafter referred to as "funds," decreased by ¥4,066 million from the end of the previous consolidated fiscal year to ¥76,806 million.」

    Cash and cash equivalents decreased from the end of the previous consolidated fiscal year to ¥76,806 million.
  8. FY2023Decrease from the end of the previous consolidated fiscal yearAnnual report

    「Cash and cash equivalents at the end of the consolidated fiscal year decreased by ¥8,458 million from the end of the previous consolidated fiscal year to ¥80,872 million.」

    Cash and cash equivalents decreased from ¥89,330 million at the end of the previous fiscal year to ¥80,872 million.
  9. FY2023-Q3Decrease from the end of the previous consolidated fiscal yearAnnual report

    「Cash and deposits 89,330 84,825」

    Cash and deposits decreased from ¥89,330 million at the end of the previous consolidated fiscal year to ¥84,825 million.
  10. FY2023-Q2Increase from the end of the previous consolidated fiscal yearAnnual report

    「Cash and cash equivalents at the end of the cumulative second quarter, hereinafter referred to as "funds," increased by ¥5,153 million from the end of the previous consolidated fiscal year to ¥94,484 million.」

    Cash and cash equivalents increased by ¥5,153 million, from ¥89,330 million at the end of the previous consolidated fiscal year to ¥94,484 million.
  11. FY2023-Q1Decrease from the end of the previous consolidated fiscal yearAnnual report

    「Cash and deposits 89,330 88,749」

    Cash and deposits decreased from ¥89,330 million at the end of the previous consolidated fiscal year to ¥88,749 million.
  12. FY2022Increase from the end of the previous consolidated fiscal yearAnnual report

    「Cash and cash equivalents at the end of the consolidated fiscal year increased by ¥2,835 million from the end of the previous consolidated fiscal year to ¥89,330 million.」

    Cash and cash equivalents increased by ¥2,835 million from the end of the previous fiscal year to ¥89,330 million.
  13. FY2022-Q3Increase from the end of the previous consolidated fiscal yearAnnual report

    「Cash and deposits 86,495 88,676」

    Cash and deposits increased by ¥2,181 million, from ¥86,495 million at the end of the previous consolidated fiscal year to ¥88,676 million.
  14. FY2022-Q2Increase from the end of the previous consolidated fiscal yearAnnual report

    「Cash and cash equivalents at the end of the cumulative second quarter, hereinafter referred to as "funds," increased by ¥3,800 million from the end of the previous consolidated fiscal year to ¥90,296 million.」

    Cash and cash equivalents increased from ¥86,495 million at the end of the previous consolidated fiscal year to ¥90,296 million, reversing the decrease recorded in the previous quarter.
  15. FY2022-Q1Decrease from the end of the previous consolidated fiscal yearAnnual report

    「Cash and deposits 86,495 85,013」

    Cash and deposits decreased from ¥86,495 million at the end of the previous consolidated fiscal year to ¥85,013 million.
  16. FY2021Increase from the end of the previous consolidated fiscal yearAnnual report

    「Cash and cash equivalents at the end of the consolidated fiscal year, hereinafter referred to as "funds," increased by ¥5,795 million from the end of the previous fiscal year to ¥86,495 million.」

    Cash and cash equivalents increased by ¥5,795 million, from ¥80,699 million at the end of the previous fiscal year to ¥86,495 million.
  17. FY2021-Q3RestatedAnnual report

    「Cash and deposits 80,699 87,433」

    Cash and deposits increased from ¥80,699 million at the end of the previous consolidated fiscal year to ¥87,433 million, an increase of ¥6,734 million.
  18. FY2021-Q2First statedAnnual report

    「Cash and cash equivalents at the end of the cumulative second quarter, hereinafter referred to as "funds," increased by ¥7,329 million from the end of the previous consolidated fiscal year to ¥88,028 million.」

    The increase in cash and cash equivalents from the end of the previous consolidated fiscal year to ¥88,028 million, an increase of ¥7,329 million, was newly recorded.
Moved together

None of this company's other threads moved the same way in the same document twice or more.

When this could move next
No upcoming earnings preview for Sundrug yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.